Angle Closure - Relevant breakthroughs in this field

2.1 Should laser peripheral iridotomy (LPI) be performed in primary angle-closure suspect (PACS) patients?
Last year we covered the EAGLE and ZAP trials. We believe valuable comments have recently been made regarding the ZAP trial that might be of interest to EGS newsletter readers.

Comments by Robert N Weinreb & Sasan Moghimi:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)33059-9/fulltext

Comments for the AAO by Swarup Swaminathan:
https://www.aao.org/editors-choice/laser-peripheral-iridotomy-offers-modest-benefits-


2.2 Should selective laser trabeculoplasty be performed in primary angle-closure glaucoma (PACG) patients?

Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial
Arun Narayanaswamy, Christopher K Leung, Donny V Istiantoro, Shamira A Perera, Ching-Lin Ho, Monisha E Nongpiur, Mani Baskaran, Hla Htoon, Tina T Wong, David Goh, Daniel H Su, Michael Belkin, Tin Aung doi:10.1001/jamaophthalmol.2014.4893

Eyes with PAC or PACG respond to SLT in the short-term, but the overall long-term therapeutic effectiveness needs further evaluation.

The search for EGS goal of “Paving the Way to Better Glaucoma Care” continues together with Outcome and other EGS Committees as well as SIGs, i.e. how to promote the best possible well-being and minimal glaucoma-induced visual disability in individuals with glaucoma within affordable healthcare systems.

The views expressed are those of the author(s) and are not necessarily those of the EGS.

SIG Corner Editor: João Barbosa Breda

Angle Closure SIG

Chair: John Thygesen
Co-chair: Gus Gazzard